NCT03333616 2026-01-21Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary TumorsDana-Farber Cancer InstitutePhase 2 Active not recruiting100 enrolled
NCT05150236 2023-12-15ANZUP2001Australian and New Zealand Urogenital and Prostate Cancer Trials GroupPhase 2 Unknown93 enrolled